K+-channel voltage-sensor paddle domain of Calcium-activated potassium channel subunit alpha-1
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 257–284 | Not recorded | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 5.5;310 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient NMR sample composition:100mM [U-2H] 98% DPC, 50mM potassium chloride, 1mM HsapBK(233-260), 90% H2O/10% D2O | 90% H2O/10% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2K44 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 10AD Cryo-EM structure of the human BK channel bound to the agonist NS1619 Deposited 2026-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1178(1113 aa)
Chain C
66–1178(1113 aa)
Chain D
66–1178(1113 aa)
Chain E
66–1178(1113 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 A1E02 3-[2-oxidanyl-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1~{H}-benzimidazol-2-one × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.44 Å |
| 3NAF Structure of the Intracellular Gating Ring from the Human High-conductance Ca2+ gated K+ Channel (BK Channel) Deposited 2010-06-01 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
394–681(288 aa)
Fragment:Intracellular Domain (UNP RESIDUES 329-616; 659-1113)
Chain A
786–1240(455 aa)
Fragment:Intracellular Domain (UNP RESIDUES 329-616; 659-1113)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;3.5M sodium formate, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 3.10 Å R-free 0.289 |
| 6ND0 human BK channel reconstituted into liposomes Deposited 2018-12-13 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
292–1175(884 aa)
Chain B
292–1175(884 aa)
Chain C
292–1175(884 aa)
Chain D
292–1175(884 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.3
cryo-EM vitrification conditions
Cryogen ETHANE;BK proteoliposomes were applied onto a glow-discharged perforated carbon grid (CFlat R2/2, EMS), and incubated for 5-10 min In an FEI Vitrobot Mark IV (FEI). After incubation, the sample was blotted from the side and buffer containing 10 mM HEPES, pH 7.3, 75 mM KCl, and 1 mM EDTA was applied onto the TEM grid to further swell proteoliposomes. Then grids were blotted for 7 s with force 0 and fast frozen in liquid ethane cooled by liquid nitrogen.
|
Resolution 3.50 Å |
| 6V22 Cryo-EM structure of Ca2+-bound hsSlo1-beta4 channel complex Deposited 2019-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Fragment:UNP residues 66-1121
Chain B
66–1121(1056 aa)
Fragment:UNP residues 66-1121
Chain C
66–1121(1056 aa)
Fragment:UNP residues 66-1121
Chain D
66–1121(1056 aa)
Fragment:UNP residues 66-1121
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 60 CLR CHOLESTEROL × 16 K POTASSIUM ION × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 4 seconds before plunging.
|
Resolution 3.20 Å |
| 6V35 Cryo-EM structure of Ca2+-free hsSlo1-beta4 channel complex Deposited 2019-11-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | PGW (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate × 40 CLR CHOLESTEROL × 8 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 4 seconds before plunging.
|
Resolution 3.50 Å |
| 6V38 Cryo-EM structure of Ca2+-bound hsSlo1 channel Deposited 2019-11-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 32 CLR CHOLESTEROL × 12 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 4 seconds before plunging.
|
Resolution 3.80 Å |
| 6V3G Cryo-EM structure of Ca2+-free hsSlo1 channel Deposited 2019-11-25 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 4 seconds before plunging.
|
Resolution 4.00 Å |
| 6V5A Crystal structure of the human BK channel gating ring L390P mutant Deposited 2019-12-03 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
406–1121(716 aa)
Fragment:Gating Ring
|
Mutation:L390P | CA CALCIUM ION × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.9;295 K;50 mM sodium acetate, 4% (w/v) PEG 4000, 100 mM sodium sulfate, and 100 mM lithium sulfate (pH 4.9)
|
Resolution 2.00 Å R-free 0.226 |
| 8GH9 Cryo-EM structure of hSlo1 in total membrane vesicles Deposited 2023-03-09 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
67–1121(1055 aa)
Chain B
67–1121(1055 aa)
Chain C
67–1121(1055 aa)
Chain D
67–1121(1055 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å |
| 8GHF cryo-EM structure of hSlo1 in plasma membrane vesicles Deposited 2023-03-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
67–1121(1055 aa)
Chain B
67–1121(1055 aa)
Chain C
67–1121(1055 aa)
Chain D
67–1121(1055 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 88 CLR CHOLESTEROL × 24 NA SODIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å |
| 8GHG Cryo-EM structure of hSlo1 in digitonin, Ca2+-free and EDTA-free Deposited 2023-03-10 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
67–1121(1055 aa)
Chain B
67–1121(1055 aa)
Chain C
67–1121(1055 aa)
Chain D
67–1121(1055 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 8V60 F315A mutant of human Slo1 in presence of EDTA - resting VSD Deposited 2023-12-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Mutation:F315A Mutation:F315A Mutation:F315A Mutation:F315A | K POTASSIUM ION × 9 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 28 CLR CHOLESTEROL × 4 AJP Digitonin × 36 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.43 Å |
| 8V63 R207A mutant of human Slo1 in presence of EDTA - activated VSD Deposited 2023-12-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Mutation:R207A Mutation:R207A Mutation:R207A Mutation:R207A | K POTASSIUM ION × 9 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 28 CLR CHOLESTEROL × 4 AJP Digitonin × 40 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.72 Å |
| 8V64 RCK1-RCK2 double mutant of human Slo1 in presence of EDTA - resting VSD Deposited 2023-12-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Mutation:D894A,D895A,D896A,D897A Mutation:D894A,D895A,D896A,D897A Mutation:D894A,D895A,D896A,D897A Mutation:D894A,D895A,D896A,D897A | K POTASSIUM ION × 9 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 24 CLR CHOLESTEROL × 4 AJP Digitonin × 36 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å |
| 8VAV Human Slo1 - human LRRC26 in presence of EDTA - GR masked Deposited 2023-12-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 20 K POTASSIUM ION × 4 AJP Digitonin × 32 CLR CHOLESTEROL × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 8VAZ Structure of human Slo1 and human LRRC26 in EDTA - LRRD masked Deposited 2023-12-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | K POTASSIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.82 Å |
| 8Z3S Activation mechanism and novel binding site of the BKCa channel activator CTIBD Deposited 2024-04-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1179(1114 aa)
Chain B
66–1179(1114 aa)
Chain C
66–1179(1114 aa)
Chain D
66–1179(1114 aa)
|
Not recorded | A1L04 4-[4-(4-chlorophenyl)-3-(trifluoromethyl)-1,2-oxazol-5-yl]benzene-1,3-diol × 8 Y01 CHOLESTEROL HEMISUCCINATE × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å |
| 9CZH Ca2+ bound intermediate state of hSlo1 + beta2N-beta4 channel in detergent. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | CA CALCIUM ION × 8 K POTASSIUM ION × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 10 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 9CZJ Ca2+ free hSlo1 + beta2N-beta4 channel in detergent. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | CLR CHOLESTEROL × 4 K POTASSIUM ION × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.54 Å |
| 9CZK Ca2+ free hSlo1 + beta2N-beta4 channel in nanodisc. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | K POTASSIUM ION × 2 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 4 CLR CHOLESTEROL × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 9CZM Ca2+ bound open-inactivated hSlo1 + beta2N-beta4 channel in nanodisc. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 32 MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 CLR CHOLESTEROL × 8 K POTASSIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.57 Å |
| 9CZO Ca2+ bound intermediate state of hSlo1 + beta2N-beta4 channel in nanodisc. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | CA CALCIUM ION × 8 K POTASSIUM ION × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 11 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.87 Å |
| 9CZQ Ca2+ bound open-inactivated hSlo1 + beta2N-beta4 channel in detergent. Deposited 2024-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 20 CLR CHOLESTEROL × 11 K POTASSIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å |
| 9D18 Ca2+ bound open-inactivated hSlo1 + beta2N-beta4 channel in detergent-conformation 2 of inactivating domain Deposited 2024-08-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 20 CLR CHOLESTEROL × 11 K POTASSIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å |
| 9D19 Ca2+ bound open-inactivated hSlo1 + beta2N-beta4 channel in detergent-conformation 3 of inactivating domain Deposited 2024-08-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
66–1121(1056 aa)
Chain B
66–1121(1056 aa)
Chain C
66–1121(1056 aa)
Chain D
66–1121(1056 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 20 CLR CHOLESTEROL × 11 K POTASSIUM ION × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;20 mM Tris-HCl pH 8.0, 450 mM KCl, 5 mM EDTA, 15 mM MgCl2, 0.02% GDN and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w).
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å |
| 9JO3 Cryo-EM structure of human BKca channel-compound 10b complex Deposited 2024-09-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1184(1119 aa)
Chain B
66–1184(1119 aa)
Chain C
66–1184(1119 aa)
Chain D
66–1184(1119 aa)
|
Not recorded | MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 K POTASSIUM ION × 3 A1L4E 5-azanyl-2-[2,3,5,6-tetrakis(fluoranyl)-4-(trifluoromethyl)phenoxy]phenol × 4 Y01 CHOLESTEROL HEMISUCCINATE × 16 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å |
| 9JO4 Cryo-EM structure of human BKca channel-compound 51b complex Deposited 2024-09-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
66–1179(1114 aa)
Chain B
66–1179(1114 aa)
Chain C
66–1179(1114 aa)
Chain D
66–1179(1114 aa)
|
Not recorded | A1L4F 5-(5-morpholin-4-ylpentylamino)-2-[2,3,5,6-tetrakis(fluoranyl)-4-(trifluoromethyl)phenoxy]phenol × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 8 K POTASSIUM ION × 3 Y01 CHOLESTEROL HEMISUCCINATE × 16 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
27 other PDB entries and 27 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | KCMA1_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–28; UniProt 257–284 |